Figure 2
![Successful depletion of peripheral blood B-cells from the low dose rituximab TT4 study. Mean at baseline 0.44x109/L [normal range 0.16-0.36], day 28 <0.01x109/L, 6 months 0.03x109/L and 12 months 0.08x109/L](https://ash.silverchair-cdn.com/ash/content_public/journal/blood/122/21/10.1182_blood.v122.21.1084.1084/3/1084f02.png.jpeg?Expires=1720817818&Signature=e2cigLj9n3XHlq5dPv-sRBr-iK6OAS1Tk44M1KDlYSPOqhaOjiSQRw-JzTavMUZfI-iWbS6GFDppPDsY52fGLzWjkmPHI0qgo1vdUus10EVZgNlElGKmkUQTMHQxC5D9Qsyo4lq3tfbKqsDpoi3GGvJoUTwCj3zpbrdEe~i8-judJAM3aZEJEzs1ZpNEKvPzQK5Jh1kJh10SHsvlca8Z8L7KwgEHBdOQUQxHtEvIMlXf222oOEj-2j-e-xyekQn2AlzpZOy66-FWDo3bXyMSzgEDMmwAm85-8lZmKrr-YtC56DeJ2nda0Xvoj0Xk6U7~PQh-3MzRO1yTzVuqYFbnkA__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)
Successful depletion of peripheral blood B-cells from the low dose rituximab TT4 study. Mean at baseline 0.44x109/L [normal range 0.16-0.36], day 28 <0.01x109/L, 6 months 0.03x109/L and 12 months 0.08x109/L
Successful depletion of peripheral blood B-cells from the low dose rituximab TT4 study. Mean at baseline 0.44x109/L [normal range 0.16-0.36], day 28 <0.01x109/L, 6 months 0.03x109/L and 12 months 0.08x109/L
